Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$2.11 - $2.94 $39,174 - $54,584
-18,566 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$16.41 - $24.71 $304,668 - $458,765
18,566 New
18,566 $305,000
Q1 2021

May 10, 2021

SELL
$20.38 - $34.07 $138,156 - $230,960
-6,779 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$19.0 - $32.63 $128,801 - $221,198
6,779 New
6,779 $210,000

About TCR2 THERAPEUTICS INC.


  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.